June 2009 Issue Table Of Contents

Editor’s Note

• Editor’s Note

Feature

• What's Next? (The answer may surprise you.)
• A Life Sciences Stimulus?

Inside The Industry

• CMO Roundtable
• Has The Downturn Changed Dealmaking?
• What Impact Will The ARRA Have On Pharma?
• Centralization Of Biochemical Screening At AstraZeneca
• Strategies For Avoiding FCPA Liability
• Drug Reimportation: Helpful Or Harmful?
• Drug Approval Trends In Europe
• Choosing The UK For Translational Medicine

Industry Leader

• Insourcing Is The New Outsourcing In Biopharma
• Think Modular
• Relationships Are Key To Best Practice Outsourcing